在尼泊尔实施即时检验以优化阴道分泌物抗生素使用:一项随机对照试验的研究方案
该研究为在尼泊尔教学医院及其外展中心开展的随机对照双盲优效性试验,纳入阴道分泌物患者并随机分三组:组1按综合征管理经验性用药,组2依据即时检验(POCT)结果指导治疗,组3在POCT基础上增加教育干预及社会心理问题转介。主要结局为主要就诊时抗生素过度治疗的比例,比较组1与组2、组3。
要点
- 在资源有限地区,POCT指导治疗可能减少阴道分泌物患者的抗生素过度使用。
- 试验比较综合征管理与POCT指导治疗,并评估叠加教育和社会心理干预的效果。
- 主要结局为主要就诊时抗生素过度治疗的比例,随访4周和4个月。
核心结论
- 该试验评估在资源有限地区将POCT整合入阴道分泌物管理的有效性和影响。
- 比较综合征管理与POCT指导诊断治疗(单独或联合社会心理与教育干预)的结果,为减少抗生素过度使用和改善更广泛生殖健康问题提供策略信息。
研究设计与样本
- 随机对照双盲优效性试验,在尼泊尔一所教学医院及其外展中心开展,随访评估在4周和4个月进行。
- 参与者随机分配至三组:组1接受基于综合征管理的治疗;组2接受POCT指导的治疗,使用Cepheid GeneXpert®(检测沙眼衣原体[Ct]和淋病奈瑟菌[Ng])、pH和whiff试验(检测细菌性阴道病[BV]和阴道毛滴虫[Tv])以及OSOM®试验(检测Tv);组3接受与组2相同的POCT指导治疗,并增加教育干预和社会心理问题转介。
- 主要结局为主要就诊时抗生素过度治疗的比例,比较组1与组2和组3。
- 次要结局包括非处方抗生素获取、后续就医行为以及阴道分泌物症状随时间的变化。
- 试验注册:ClinicalTrials.gov NCT05977491,注册日期2023年4月8日;方案版本6,2025年10月30日。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Vaginal discharge (VD) is a common health concern among women of reproductive age worldwide. In low- and lower-middle-income countries (LLMICs), one in four women experiences distressing VD which may indicate underlying infections. About one-third of these cases are caused by one of three curable sexually transmitted infections (STIs)-Chlamydia trachomatis [Ct], Neisseria gonorrhea [Ng], Trichomonas vaginalis [Tv]-or by bacterial vaginosis (BV). Syndromic management, the standard approach to care in LLMICs, relies on empirical antibiotic treatment, often resulting in overtreatment and contributing to antimicrobial resistance. To reduce unnecessary use of antibiotics, affordable, accurate, and rapid diagnostic tests such as point-of-care tests (POCTs) are needed-particularly in settings where over-the-counter antibiotic use is common and psychosocial problems may be somatized. Additionally, education on VD and appropriate antibiotic use, along with recognition of mental health or domestic violence issues, may be important for facilitating acceptance of POCTs. METHODS: This study is a randomized controlled double-blind, superiority trial with follow-up assessments at 4 weeks and 4 months conducted in a Nepalese teaching hospital and its outreach centers. Participants are randomly assigned to one of three study arms: Arm 1 receives treatment, based on syndromic management; Arm 2 receives POCT-guided treatment using the Cepheid GeneXpert® (for Ct and Ng), pH and whiff tests (for BV and Tv), and the OSOM® test (for Tv); Arm 3 receives the same POCT-guided treatment as Arm 2, plus an educational intervention, and referral for psychosocial concerns. The primary outcome is the proportion of participants overtreated with antibiotics at the primary consultation, comparing Arm 1 versus Arms 2 and 3. Secondary outcomes include over-the-counter antibiotic acquisition, subsequent health-seeking behavior, and changes in VD symptom development over time. DISCUSSION: The trial assesses the effectiveness and impact of integrating POCTs into VD management in a resource-limited setting. Results of comparing syndromic-based management with POCT-guided diagnostic testing and treatment, both alone and combined with psychosocial and education-based interventions, inform strategies to reduce antibiotic overuse and improve broader reproductive health concerns. TRIAL REGISTRATION: ClinicalTrials.gov NCT05977491. Registered on 8 April 2023. https://clinicaltrials.gov/study/NCT05977491?cond=vaginal%20discharge&rank=6 PROTOCOL VERSION: Version 6, October 30, 2025.
引用
- Shrestha S, Shakya S, Infanti JJ, et al. Implementing point-of-care tests to optimize antibiotic use for vaginal discharge: a study protocol for a randomized controlled trial in Nepal. Trials. 2025. PMID: 41388307. doi:10.1186/s13063-025-09333-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。